Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproic acid as second-line treatment for hormone-refractory metastatic prostate cancer
2006-003554-15Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of valproic acid in prostate cancer (PCa), sponsored by National Cancer Institute. Primary endpoint: Response rate. Started Sep 2006; status: completed.
02
Drugs
valproic acid
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2006-003554-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003554-15.